MX385262B - Nuevos productos inmunobiologicos - Google Patents
Nuevos productos inmunobiologicosInfo
- Publication number
- MX385262B MX385262B MX2018010495A MX2018010495A MX385262B MX 385262 B MX385262 B MX 385262B MX 2018010495 A MX2018010495 A MX 2018010495A MX 2018010495 A MX2018010495 A MX 2018010495A MX 385262 B MX385262 B MX 385262B
- Authority
- MX
- Mexico
- Prior art keywords
- allergic
- compound
- dermatitis
- present
- modified chitosan
- Prior art date
Links
- 230000001900 immune effect Effects 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 abstract 5
- 208000010668 atopic eczema Diseases 0.000 abstract 5
- 230000000172 allergic effect Effects 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000416 hydrocolloid Substances 0.000 abstract 4
- 208000004396 mastitis Diseases 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 201000004624 Dermatitis Diseases 0.000 abstract 2
- 206010012442 Dermatitis contact Diseases 0.000 abstract 2
- 208000004145 Endometritis Diseases 0.000 abstract 2
- 206010015150 Erythema Diseases 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 2
- 208000011623 Obstructive Lung disease Diseases 0.000 abstract 2
- 208000002474 Tinea Diseases 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 2
- 230000007815 allergy Effects 0.000 abstract 2
- 230000001684 chronic effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 231100000321 erythema Toxicity 0.000 abstract 2
- 208000017520 skin disease Diseases 0.000 abstract 2
- 201000010153 skin papilloma Diseases 0.000 abstract 2
- 206010007882 Cellulitis Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010010741 Conjunctivitis Diseases 0.000 abstract 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012504 Dermatophytosis Diseases 0.000 abstract 1
- 208000006413 Digital Dermatitis Diseases 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 241001460074 Microsporum distortum Species 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 206010067409 Trichophytosis Diseases 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 208000002205 allergic conjunctivitis Diseases 0.000 abstract 1
- 208000002029 allergic contact dermatitis Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 238000003975 animal breeding Methods 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 208000024998 atopic conjunctivitis Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 210000000078 claw Anatomy 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 208000023867 digital dermatitis in cattle Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 208000024386 fungal infectious disease Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000030175 lameness Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Tires In General (AREA)
- Dental Preparations (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a un procedimiento que comprende la etapa de incubar quitosano en una solución acuosa de un ácido carboxílico orgánico o una sal del mismo, un quitosano modificado que puede obtenerse mediante el procedimiento de la presente invención, un hidrocoloide, un compuesto de fórmula [X]n, una composición que comprende el quitosano modificado, el hidrocoloide o el compuesto de acuerdo con la presente invención, el quitosano modificado, el hidrocoloide, el compuesto o la composición de acuerdo con la presente invención para su uso en seres humanos y/o en medicina veterinaria y el quitosano modificado, el hidrocoloide, el compuesto o la composición de acuerdo con la presente invención para su uso en un procedimiento para tratar y/o prevenir mastitis, preferentemente mastitis latente y/o mastitis aguda, endometritis, preferentemente endometritis crónica, aguda y/o purulenta-catarral, enfermedades podales y de las pezuñas, cojera, lesiones en el espacio interdigital, dermatitis digital, dermatitis interdigital, flemón interdigital, tricofitosis, microesporosis, micosis de la piel, alergias, así como enfermedades complicadas por alergias, en particular, enfermedad pulmonar obstructiva alérgica, enfermedades alérgicas de la piel, eritema alérgico del oído, rinitis alérgica, conjuntivitis alérgica, dermatitis de contacto alérgica aguda, eccema de contacto alérgico crónico o eccema atópico, enfermedad pulmonar obstructiva, en particular enfermedad pulmonar obstructiva crónica, dermopatías, en particular, dermatitis, eritema del oído, rinitis, conjuntivitis, dermatofitosis o verrugas, en particular verrugas comunes, en un sujeto y para modular la respuesta inmunitaria en un sujeto y/o para mejorar la eficacia de la reproducción, preferentemente la eficacia de la reproducción en la cría de animales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16160534 | 2016-03-15 | ||
| PCT/EP2017/056146 WO2017158040A1 (en) | 2016-03-15 | 2017-03-15 | New immunobiological products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018010495A MX2018010495A (es) | 2019-03-28 |
| MX385262B true MX385262B (es) | 2025-03-14 |
Family
ID=55588088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018010495A MX385262B (es) | 2016-03-15 | 2017-03-15 | Nuevos productos inmunobiologicos |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11173193B2 (es) |
| EP (1) | EP3429600B1 (es) |
| CN (1) | CN109152793B (es) |
| AU (1) | AU2017234986C1 (es) |
| CA (1) | CA3017673C (es) |
| CY (1) | CY1124290T1 (es) |
| DK (1) | DK3429600T3 (es) |
| EA (1) | EA037516B1 (es) |
| ES (1) | ES2878071T3 (es) |
| HR (1) | HRP20210801T1 (es) |
| HU (1) | HUE054207T2 (es) |
| IL (1) | IL261780B (es) |
| LT (1) | LT3429600T (es) |
| MX (1) | MX385262B (es) |
| PL (1) | PL3429600T3 (es) |
| PT (1) | PT3429600T (es) |
| RS (1) | RS61885B1 (es) |
| SI (1) | SI3429600T1 (es) |
| SM (1) | SMT202100318T1 (es) |
| UA (1) | UA124929C2 (es) |
| WO (1) | WO2017158040A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3429616T1 (sl) | 2016-03-15 | 2021-12-31 | Igor Polyakov | Sestavki za zdravljenje in preprečevanje bolezni kopit in krempljev |
| EP3429600B1 (en) | 2016-03-15 | 2021-03-03 | Igor Polyakov | New immunobiological products |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2304347A (en) | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
| EP0834322A3 (en) | 1996-10-04 | 1998-04-22 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Mycosis vaccine |
| ES2936312T3 (es) * | 2011-08-31 | 2023-03-16 | Perosphere Tech Inc | Métodos para la desensibilización eficaz y rápida de pacientes alérgicos |
| CN102727887B (zh) * | 2012-07-12 | 2014-04-02 | 中国人民解放军第三军医大学第二附属医院 | 壳聚糖作为免疫佐剂在制备小鼠过敏性哮喘模型中的用途 |
| EP3429600B1 (en) | 2016-03-15 | 2021-03-03 | Igor Polyakov | New immunobiological products |
-
2017
- 2017-03-15 EP EP17711627.4A patent/EP3429600B1/en active Active
- 2017-03-15 ES ES17711627T patent/ES2878071T3/es active Active
- 2017-03-15 AU AU2017234986A patent/AU2017234986C1/en active Active
- 2017-03-15 SI SI201730754T patent/SI3429600T1/sl unknown
- 2017-03-15 UA UAA201809801A patent/UA124929C2/uk unknown
- 2017-03-15 CA CA3017673A patent/CA3017673C/en active Active
- 2017-03-15 HU HUE17711627A patent/HUE054207T2/hu unknown
- 2017-03-15 US US16/085,033 patent/US11173193B2/en active Active
- 2017-03-15 DK DK17711627.4T patent/DK3429600T3/da active
- 2017-03-15 PL PL17711627T patent/PL3429600T3/pl unknown
- 2017-03-15 RS RS20210639A patent/RS61885B1/sr unknown
- 2017-03-15 WO PCT/EP2017/056146 patent/WO2017158040A1/en not_active Ceased
- 2017-03-15 CN CN201780017269.2A patent/CN109152793B/zh active Active
- 2017-03-15 LT LTEP17711627.4T patent/LT3429600T/lt unknown
- 2017-03-15 SM SM20210318T patent/SMT202100318T1/it unknown
- 2017-03-15 PT PT177116274T patent/PT3429600T/pt unknown
- 2017-03-15 MX MX2018010495A patent/MX385262B/es unknown
- 2017-03-15 HR HRP20210801TT patent/HRP20210801T1/hr unknown
- 2017-03-15 EA EA201891934A patent/EA037516B1/ru unknown
-
2018
- 2018-09-13 IL IL261780A patent/IL261780B/en unknown
-
2021
- 2021-05-27 CY CY20211100458T patent/CY1124290T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190125846A1 (en) | 2019-05-02 |
| DK3429600T3 (da) | 2021-05-25 |
| WO2017158040A1 (en) | 2017-09-21 |
| CN109152793A (zh) | 2019-01-04 |
| EA037516B1 (ru) | 2021-04-07 |
| IL261780B (en) | 2021-10-31 |
| US11173193B2 (en) | 2021-11-16 |
| SMT202100318T1 (it) | 2021-07-12 |
| LT3429600T (lt) | 2021-06-10 |
| RS61885B1 (sr) | 2021-06-30 |
| SI3429600T1 (sl) | 2021-08-31 |
| PL3429600T3 (pl) | 2021-09-13 |
| PT3429600T (pt) | 2021-05-17 |
| CY1124290T1 (el) | 2022-07-22 |
| ES2878071T3 (es) | 2021-11-18 |
| HUE054207T2 (hu) | 2021-08-30 |
| AU2017234986B2 (en) | 2022-04-07 |
| CA3017673A1 (en) | 2017-09-21 |
| AU2017234986A1 (en) | 2018-08-16 |
| CN109152793B (zh) | 2022-05-17 |
| MX2018010495A (es) | 2019-03-28 |
| AU2017234986C1 (en) | 2022-08-18 |
| EA201891934A1 (ru) | 2019-03-29 |
| UA124929C2 (uk) | 2021-12-15 |
| EP3429600A1 (en) | 2019-01-23 |
| CA3017673C (en) | 2023-03-07 |
| EP3429600B1 (en) | 2021-03-03 |
| HRP20210801T1 (hr) | 2021-06-25 |
| IL261780A (en) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110036014A (zh) | 一种具有axl抑制活性的化合物及其制备和应用 | |
| EA201270566A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| EA201270567A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| EA201300669A1 (ru) | Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение | |
| HK1215868A1 (zh) | 双特异性构建体及其用於治疗多种疾病的用途 | |
| MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
| HK1219943A1 (zh) | 用於治疗眼科疾病和障害的取代3-苯基丙胺衍生物 | |
| NZ714684A (en) | Stable oral solutions for combined api | |
| WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
| MX2019014935A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
| EP3402872A4 (en) | MILKIC ACID USE BACTERIA GENETICALLY MODIFIED TO POLYSACCHARIDE-DERIVED ENZYMES | |
| EA201592254A1 (ru) | Производные пиразолопирролидин-4-она и их применение при лечении заболевания | |
| CY1125179T1 (el) | Παραγωγα πυραζολιου χρησιμα ως αναστολεις της πρωτεïνης ενεργοποιησης της 5-λιποξυγενασης (flap) | |
| BR112017008184A2 (pt) | composições e linhagem | |
| MX390290B (es) | Sal farmacéuticamente aceptable de alquilcarbamoil naftaleniloxi octenoilhidroxiamida o de sus derivados y sus métodos de preparación. | |
| ZA201904591B (en) | Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs | |
| MX385262B (es) | Nuevos productos inmunobiologicos | |
| NZ706573A (en) | Ciclesonide for the treatment of airway disease in horses | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| EA201591704A1 (ru) | Новые устойчивые соли пентадекапептида, способ их получения, их применение в производстве фармацевтических составов и их применение в терапии | |
| NZ613554A (en) | Caprylate viral deactivation | |
| CN109496212A (zh) | 一种喹啉基取代的羧酸化合物或其药学上可接受的盐、其药物组合物及应用 | |
| CN104543490A (zh) | 幼蚕饲料添加剂及其使用方法 | |
| CN110418787A (zh) | 一种吲哚乙酸类衍生物及其制备方法和医药用途 | |
| CN103285399B (zh) | 一种皮上划痕用布氏菌活疫苗冻干保护剂 |